{"id":"W4386277882","doi":"10.1016/s2152-2650(23)01205-3","title":"MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; School of Medicine, Vanderbilt University; Yale Cancer Center; Yale University; Vanderbilt-Ingram Cancer Center; Vanderbilt University; London Health Sciences Centre; University of Texas MD Anderson Cancer Center; Roswell Park Cancer Institute","keywords":"Decitabine; Phase (matter); Medicine; Internal medicine; Oncology; Chemistry; Biology; Genetics; Organic chemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008023359,0.000542002,0.001094794,0.00035992,0.0004788307,0.0006053991,0.0004032795,0.0004284786,0.003449472],"category_scores_gemma":[0.0004640445,0.0002278864,0.0007389917,0.0003192131,0.0003257177,0.0003301559,0.0003529381,0.001360753,0.0007096664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006820868,"about_ca_system_score_gemma":0.0009378671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001401973,"about_ca_topic_score_gemma":0.00473507,"domain_scores_codex":[0.9997745,0.00008016774,0.00001729116,0.0000270857,0.00004111008,0.00005978374],"domain_scores_gemma":[0.9998149,0.00002811157,0.0000351347,0.00002115093,0.00003143465,0.0000691659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2893511,0.01336277,0.01629423,0.0009485275,0.001380757,0.0003895427,0.000480315,0.004538368,0.2716846,0.0005697695,0.008569297,0.3924306],"study_design_scores_gemma":[0.1645721,0.5062943,0.1429124,0.0002133506,0.002615491,0.001883651,0.0004121724,0.003969998,0.1294345,0.001286592,0.04627592,0.0001296507],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924591,0.002615653,0.0004137099,0.000344904,0.00003424662,0.0003657969,0.001140033,0.0001064872,0.002520024],"genre_scores_gemma":[0.9912635,0.00136791,0.0007717206,0.0002309148,0.00002946472,0.0003167774,0.003225992,0.00002844614,0.002765237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003449472,"threshold_uncertainty_score":0.01153964,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1173102328730523,"score_gpt":0.4757566492205611,"score_spread":0.3584464163475088,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}